La vida de Pedro el grande, Zar de Russia /

Por Oudard, Georges.
Publicado em [s.d

Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxicities

Por Cohen, Roger B., Oudard, Stéphane
Publicado em 2012

Le diagnostic dans les affections de la colonne vertebrale chez l'adulte /

Por Oudard, P., Hesnard, A., Coureaud, H.
Publicado em 1928.

Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients

Por Laé, M., Couturier, J., Oudard, S., Radvanyi, F., Beuzeboc, P., Vieillefond, A.
Publicado em 2010

Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line.

Por Miccoli, L, Oudard, S, Sureau, F, Poirson, F, Dutrillaux, B, Poupon, M F
Publicado em 1996

Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma

Por Combe, Pierre, de Guillebon, Eleonore, Thibault, Constance, Granier, Clémence, Tartour, Eric, Oudard, Stéphane
Publicado no Oncoimmunology (2015)

Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib

Por Billemont, B, Medioni, J, Taillade, L, Helley, D, Meric, J B, Rixe, O, Oudard, S
Publicado em 2008

Complete remission of pulmonary metastases of Bellini duct carcinoma with cisplatin, gemcitabine and bevacizumab

Por Barrascout, Eduardo, Beuselinck, Benoit, Ayllon, Jorge, Bättig, Basil, Moch, Holger, Teghom, Corine, Oudard, Stephane
Publicado em 2012

Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors

Por Karaki, Soumaya, Anson, Marie, Tran, Thi, Giusti, Delphine, Blanc, Charlotte, Oudard, Stephane, Tartour, Eric
Publicado no Vaccines (Basel) (2016)

Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma

Por Jebali, M., Elaidi, R., Brizard, M., Fouque, J., Takouchop, C., Sabatier, B., Oudard, S., Medioni, J.
Publicado no BMC Cancer (2017)

SORAFENIB FOR OLDER PATIENTS WITH RENAL CELL CARCINOMA: SUBSET ANALYSIS FROM A RANDOMIZED TRIAL

Por T. Eisen, S. Oudard, C. Szczylik, G. Gravis, H. Heinzer, R. Middleton, F. Cihon, S. Anderson, S. Shah, R. Bukowski
Publicado em 2009-06-01

SORAFENIB FOR OLDER PATIENTS WITH RENAL CELL CARCINOMA: SUBSET ANALYSIS FROM A RANDOMIZED TRIAL

Por T. Eisen, S. Oudard, C. Szczylik, G. Gravis, H. Heinzer, R. Middleton, F. Cihon, S. Anderson, S. Shah, R. Bukowski
Publicado em 2014-08-01

Targeting Resident Memory T Cells for Cancer Immunotherapy

Por Blanc, Charlotte, Hans, Sophie, Tran, Thi, Granier, Clemence, Saldman, Antonin, Anson, Marie, Oudard, Stephane, Tartour, Eric
Publicado no Front Immunol (2018)

Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges

Por Fournier, Laure, Bellucci, Alexandre, Vano, Yann, Bouaboula, Mehdi, Thibault, Constance, Elaidi, Reza, Oudard, Stephane, Cuenod, Charles
Publicado no Kidney Cancer (2017)

High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss.

Por Oudard, S., Arvelo, F., Miccoli, L., Apiou, F., Dutrillaux, A. M., Poisson, M., Dutrillaux, B., Poupon, M. F.
Publicado em 1996

Renal malacoplakia: Case report of a differential diagnosis for renal cell carcinoma

Por Ayllon, Jorge, Verkarre, Virginie, Scotté, Florian, Fournier, Laure, Corréas, Jean Michel, Mejean, Arnaud, Teghom, Corine, Oudard, Stéphane
Publicado em 2012

Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients

Por Vano, Yann-Alexandre, Oudard, Stéphane, By, Marie-Agnès, Têtu, Pauline, Thibault, Constance, Aboudagga, Hail, Scotté, Florian, Elaidi, Reza
Publicado no PLoS One (2018)

THE SIDE EFFECTS OF SORAFENIB, SUNITINIB, AND TEMSIROLIMUS AND THEIR THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

Por N. Bhojani, C. Jeldres, J.-J. Patard, P. Perrotte, N. Suardi, G. Hutterer, F. Patenaude, S. Oudard, P. I. Karakiewicz
Publicado em 2009-12-01

Cloud thermodynamic phase inferred from merged POLDER and MODIS data

Por J. Riedi, B. Marchant, S. Platnick, B. A. Baum, F. Thieuleux, C. Oudard, F. Parol, J.-M. Nicolas, P. Dubuisson
Publicado em 2010-12-01

Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer

Por Granier, Clemence, De Guillebon, Eleonore, Blanc, Charlotte, Roussel, Helene, Badoual, Cecile, Colin, Elia, Saldmann, Antonin, Gey, Alain, Oudard, Stephane, Tartour, Eric
Publicado no ESMO Open (2017)